Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinations

British Journal of Ophthalmology

Volumn 96, Issue 4, 2012, Pages 591-596

  Westekemper, Henrike ^a   Freistuehler, Michael ^a   Anastassiou, Gerasimos ^a   Nareyeck, Gordon ^a   Bornfeld, Norbert ^a   Steuhl, Klaus Peter ^a   Scheulen, Max E ^a   Hilger, Ralf A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FOTEMUSTINE; IMATINIB; MITOMYCIN C; RETINOIC ACID; SULFORHODAMINE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MONOTHERAPY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CONJUNCTIVAL NEOPLASMS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MELANOMA;

EID: 84858340177     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300686     Document Type: Article

References (29)

1. Shields CL. Conjunctival melanoma: risk factors for recurrences, exenteration, metastasis and death in 150 consecutive patients. Trans Am Ophthalmol Soc 2000;98:471-92. (Pubitemid 32059519)
2. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969e1991. Acta Ophthalmol Scand 1992;70:289-96.
3. Hurst E, Harbour J, Cornelius L. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 2003;139:1067-73. (Pubitemid 36994834)
4. Missotten GS, Keijser S, de Keizer RJ. Cytotoxic effect of sodium hypochlorite 0.5% (NaOCl) on ocular melanoma cells in vitro. Orbit 2008;27:31-5. (Pubitemid 351322880)
5. Donato LJ, Suh JH, Noy N. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res 2007;67:609-15. (Pubitemid 46192199)
6. Shaw N, Elholm M, Noy N. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. J Biol Chem2003;278:41589-92. (Pubitemid 37310413)
7. Zhang H, Rosdahl I. Expression profiles of p53, p21, bax and bcl-2 proteins in alltrans-retinoic acid treated primary and metastatic melanoma cells. Int J Oncol 2004;25:303-8.
8. Aebi S, Kroning R, Cenni B, et al. All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells. Clin Cancer Res 1997;3:2033-8. (Pubitemid 27505130)
9. Trimmer E, Essigmann J. Cisplatin. Essays Biochem 1999;34:191-211. (Pubitemid 129638938)
10. Naumann S, Roos W, Jo E, et al. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. Br J Cancer 2009;100:322-33.
11. Avril M, Aamdal S, Grob J, et al. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 2004;22:1118-25. (Pubitemid 41095046)
12. Buchdunger E, O'Reilly T, Wood J. Pharmacology of imatinib (STI571). Eur J Cancer 2002;38:S28-36.
13. Hamay A, Richon C, Meslin F, et al. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation. Oncogene 2006;25:7618-34. (Pubitemid 44924475)
14. Forth W, Henschler D, Rummel W. Allgemeine und spezielle Pharmakologie und Toxikologie. 5.Aufl. Mannheim Wien Zürich: Wissenschaftsverlag, 1987:731-7.
15. Finger P, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82:476-9. (Pubitemid 28266415)
16. Pe'er J, Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol 2005;139:229-34. (Pubitemid 40288265)
17. Cunneen T, Conway R, Madigan M. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. Arch Ophthalmol 2009;127:414-20.
18. Nareyeck G, Wuestemeyer H, von der Haar D, et al. Establishment of two cell lines derived from conjunctival melanomas. Exp Eye Res 2005;81:361-2. (Pubitemid 41208171)
19. Damato B, Coupland S. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol 2008;36:786-95.
20. Tschentscher F, Prescher G, Zeschnigk M, et al. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000;122:13-17.
21. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12. (Pubitemid 20213250)
22. Hudson L, Ertl A, Gill G. Structure and inducible regulation of the human c-erb B2/neu promoter. J Biol Chem 1990;265:4389-93. (Pubitemid 20096104)
23. Liu X, Chan S, Ho P. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumour development and metastasis of melanoma. Cancer Chemother Pharmacol 2008;63:167-74.
24. Jozan S, Paute S, Courtade-Saidi M, et al. All trans retinoic acid enhances CDDP-induced apoptosis: modulation of the CDDP effect on cell cycle progression. Int J Oncol 2002;20:1289-95.
25. Velpandian T, Sihota R, Sinha A, et al. Transconjunctival penetration of mitomycin C. Indian J Ophthalmol 2008;56:195-9.
26. Zhu Q, Liu JY, Yang CM, et al. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol 2006;18:1071-7. (Pubitemid 44379360)
27. Choudhury A, Zhao H, Jalali F, et al. Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity. Mol Cancer Ther 2009;8:203-13.
28. Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy. Cancer Sci 2008;99:187-94. (Pubitemid 351228469)
29. Pegg A. Repair of O6-alkylguanine by alkyltransferases. Mutat Res 2000;462:83-100.